These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2442934)

  • 1. T- and B-lymphocytes in pemphigus vulgaris. A clinico-immunological follow-up study of fifty patients with pemphigus vulgaris.
    Mashkilleyson N
    Acta Derm Venereol; 1987; 67(3):218-24. PubMed ID: 2442934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [When is it possible to discontinue therapy in pemphigus vulgaris?].
    Mashkilleyson N; Eskelinen A
    Z Hautkr; 1986 Nov; 61(22):1596-602. PubMed ID: 3101298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin action in pemphigus vulgaris: clinical and immunologic studies.
    Mashkilleyson NA
    Acta Derm Venereol; 1985; 65(6):545-7. PubMed ID: 2420123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid.
    Joffe MI; Sukha NR; Rabson AR
    J Clin Invest; 1983 Sep; 72(3):971-80. PubMed ID: 6604071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in patients with less than pemphigus vulgaris greater than before, during and after prolonged treatment with steroids.
    Shohat B; David M; Feuerman EJ
    Biomedicine; 1981 Jul; 35(3):101-3. PubMed ID: 6974011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T; Fehér J; Jakab L
    Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
    Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
    J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.
    Shiratsuchi H; Tsuyuguchi I
    Clin Exp Immunol; 1984 Aug; 57(2):271-8. PubMed ID: 6331920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies.
    de Bruin HG; Astaldi A; Leupers T; van de Griend RJ; Dooren LJ; Schellekens PT; Tanke HJ; Roos M; Vossen JM
    J Immunol; 1981 Jul; 127(1):244-51. PubMed ID: 6787124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin 2 deficiency in pemphigus vulgaris].
    Blitstein-Willinger E; Stüttgen G
    Z Hautkr; 1986 Jan; 61(1-2):82-5. PubMed ID: 3082083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral blood T-lymphocytes in pemphigus].
    Mashkilleĭson NA
    Vestn Dermatol Venerol; 1980 May; (5):10-3. PubMed ID: 6966871
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycosis fungoides. Peripheral T cell subsets defined by specific monoclonal antibodies.
    Valsecchi R; Reseghetti A; Bontempelli M; Frigeni A; Cainelli T
    Dermatologica; 1984; 169(1):12-7. PubMed ID: 6236114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.
    Bernengo MG; Lisa F; Puiatti P; Meregalli M; Berruto G; Zina G
    Thymus; 1983 Apr; 5(3-4):223-33. PubMed ID: 6224319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies.
    Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W
    Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mast cells and T-lymphocytes in pemphigus vulgaris: significance of CD44 and the c-kit gene product (CD117).
    Ghaly NR; Roshdy OA; Nassar SA; Hamad SM; El-Shafei AM
    East Mediterr Health J; 2005; 11(5-6):1009-17. PubMed ID: 16761672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of direct immunofluorescence in predicting remission in pemphigus vulgaris.
    Balighi K; Taheri A; Mansoori P; Chams C
    Int J Dermatol; 2006 Nov; 45(11):1308-11. PubMed ID: 17076711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphocyte subsets in primary lung cancer.
    Tsuyuguchi I; Shiratsuchi H; Fukuoka M
    Jpn J Clin Oncol; 1987 Mar; 17(1):13-7. PubMed ID: 3494139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Arin MJ; Engert A; Krieg T; Hunzelmann N
    Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberration of B and T cell subsets in patients with IgA nephropathy and membranous nephropathy.
    Suga T; Endoh M; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1984 Jun; 9(2):95-101. PubMed ID: 6398930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.